Funding for this research was provided by:
Text and Data Mining valid from 2019-11-05
Received: 2 April 2019
Accepted: 13 August 2019
First Online: 5 November 2019
Ethics approval and consent to participate
: The New England IRB provided review and approval for this study (#120160879) in Needham, MA on August 19, 2016. Participants provided consent by completing the survey.
: Not applicable.
: CMA, CFB, and LN are employees of GSK and hold stocks and shares in GSK. PTJ, JW, and BE are employees of Optum, which was contracted by GSK to conduct the study. Employees of Optum were not paid for manuscript development.